Clinicopathologic findings in eyes with retained perfluoro-n-octane liquid
- PMID: 11150263
- DOI: 10.1016/s0161-6420(00)00481-4
Clinicopathologic findings in eyes with retained perfluoro-n-octane liquid
Abstract
Objective: To describe the clinical and histopathologic findings in five eyes with retained perfluoro-n-octane (PFO) liquid after retinal reattachment surgery.
Design: Retrospective, noncomparative, clinicopathologic case series.
Participants: Surgical specimens from five eyes were studied.
Methods: Surgical specimens from eyes with prior intraoperative PFO use submitted to the W. Richard Green Eye Pathology Laboratory at the Wilmer Ophthalmological Institute were identified and reviewed.
Main outcome measures: Histopathologic analysis and energy dispersive spectroscopy identified intracellular vacuoles containing PFO.
Results: Five cases were identified. Three specimens were obtained at the time of further surgery for recurrent retinal detachment; one at repeat penetrating keratoplasty, and one at removal of retained PFO. Each eye had macroscopic white flake-like material on intraocular structures noted before or during surgery. Histopathologic analysis disclosed an inflammatory response featuring macrophages with intracellular vacuoles containing PFO. Removal of the PFO in all five eyes combined with repeat retinal reattachment surgery in three eyes resulted in resolution of the inflammatory response.
Conclusions: Retention of PFO after surgery elicits an inflammatory response. We suspect that young patients, those with considerable residual vitreous gel, and eyes with larger amounts of retained PFO may be at higher risk for this complication.
Similar articles
-
Outcomes of surgery for retinal detachment associated with proliferative vitreoretinopathy using perfluoro-n-octane: a multicenter study.Am J Ophthalmol. 2003 Sep;136(3):454-63. doi: 10.1016/s0002-9394(03)00241-1. Am J Ophthalmol. 2003. PMID: 12967798 Clinical Trial.
-
Outcomes and complications associated with giant retinal tear management using perfluoro-n-octane.Ophthalmology. 2002 Oct;109(10):1828-33. doi: 10.1016/s0161-6420(02)01184-3. Ophthalmology. 2002. PMID: 12359602 Clinical Trial.
-
Perfluoroperhydrophenanthrene versus perfluoro-n-octane in vitreoretinal surgery.Ophthalmology. 2000 Jun;107(6):1078-82. doi: 10.1016/s0161-6420(00)00095-6. Ophthalmology. 2000. PMID: 10857826 Clinical Trial.
-
Foreign body response within postoperative perfluoro-N-octane for retinal detachment repair: clinical features, grading system, and histopathology.Retina. 2014 Feb;34(2):237-46. doi: 10.1097/IAE.0b013e31829d002e. Retina. 2014. PMID: 23881228
-
Retained Intraocular Perfluoro-n-octane After Valved Cannula Pars Plana Vitrectomy for Retinal Detachment.Ophthalmic Surg Lasers Imaging Retina. 2015 Apr;46(4):451-6. doi: 10.3928/23258160-20150422-08. Ophthalmic Surg Lasers Imaging Retina. 2015. PMID: 25970866
Cited by
-
Evaluation of Cytotoxicity of Perfluorocarbons for Intraocular Use by Cytotoxicity Test In Vitro in Cell Lines and Human Donor Retina Ex Vivo.Transl Vis Sci Technol. 2019 Oct 17;8(5):24. doi: 10.1167/tvst.8.5.24. eCollection 2019 Sep. Transl Vis Sci Technol. 2019. PMID: 31637104 Free PMC article.
-
Perfluorocarbon liquid: its application in vitreoretinal surgery and related ocular inflammation.Biomed Res Int. 2014;2014:250323. doi: 10.1155/2014/250323. Epub 2014 Mar 30. Biomed Res Int. 2014. PMID: 24800216 Free PMC article. Review.
-
New technique for removal of perfluorocarbon liquid related sticky silicone oil and literature review.Int J Ophthalmol. 2021 Dec 18;14(12):1903-1908. doi: 10.18240/ijo.2021.12.14. eCollection 2021. Int J Ophthalmol. 2021. PMID: 34926206 Free PMC article.
-
Nine years of retained perfluoro-n-octane in the anterior chamber after retinal detachment repair with no signs of ocular toxicity.Middle East Afr J Ophthalmol. 2014 Jul-Sep;21(3):279-82. doi: 10.4103/0974-9233.134697. Middle East Afr J Ophthalmol. 2014. PMID: 25100918 Free PMC article.
-
H-Content Is Not Predictive of Perfluorocarbon Ocular Endotamponade Cytotoxicity in Vitro.ACS Omega. 2019 Aug 2;4(8):13481-13487. doi: 10.1021/acsomega.9b01793. eCollection 2019 Aug 20. ACS Omega. 2019. PMID: 31460477 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources